CH1111415295
Impact Score
Sandoz, a division of Novartis, is a global leader in generic pharmaceuticals and biosimilars aimed at improving access to medical treatments.
Impact Score
Metric | Value | Unit | Year | PDF Name | PDF Page | |
---|---|---|---|---|---|---|
Employee turnover rate | ||||||
13,1 | % | 2023 | 2023-Integrated-Annual-Report.pdf | 234 | ||
Gender Pay Gap | ||||||
3,7 | % | 2023 | 2023-Integrated-Annual-Report.pdf | 235 | ||
Glass Ceiling | ||||||
37 | % | 2023 | 2023-Integrated-Annual-Report.pdf | 234 | ||
53 | % | 2023 | 2023-Integrated-Annual-Report.pdf | 234 | ||
Greenhouse Gas Emissions | ||||||
82,85 | 1 000 tCo2e | 2023 | 2023-Integrated-Annual-Report.pdf | 232 | ||
23 848 | Headcount | 2023 | 2023-Integrated-Annual-Report.pdf | 234 | ||
129,26 | 1 000 tCo2e | 2023 | 2023-Integrated-Annual-Report.pdf | 232 | ||
Harassment and Discrimination at the Workplace | ||||||
Yes | 2023 | 2023-Integrated-Annual-Report.pdf | 67 | |||
Yes | 2023 | 2023-Integrated-Annual-Report.pdf | 65 | |||
Yes | 2023 | Sandoz-Code-of-Ethics.pdf | 11 | |||
Yes | 2023 | 2023-Integrated-Annual-Report.pdf | 67 | |||
Supply Chain | ||||||
82,85 | 1 000 tCo2e | 2023 | 2023-Integrated-Annual-Report.pdf | 232 | ||
2 051,66 | 1 000 tCo2e | 2023 | 2023-Integrated-Annual-Report.pdf | 232 | ||
129,26 | 1 000 tCo2e | 2023 | 2023-Integrated-Annual-Report.pdf | 232 | ||
23 848 | Headcount | 2023 | 2023-Integrated-Annual-Report.pdf | 234 | ||
Recycling and Recovery of Waste | ||||||
81 | % | 2023 | 2023-Integrated-Annual-Report.pdf | 233 | ||
Women on the Board | ||||||
5 | Executive | 2023 | 2023-Integrated-Annual-Report.pdf | 82 | ||
4 | Board | 2023 | 2023-Integrated-Annual-Report.pdf | 76 | ||
9 | Board | 2023 | 2023-Integrated-Annual-Report.pdf | 76 | ||
10 | Executive | 2023 | 2023-Integrated-Annual-Report.pdf | 82 | ||
Women in Management | ||||||
37 | % | 2023 | 2023-Integrated-Annual-Report.pdf | 234 |